Research
Biography
Gabrielle Mills is a first year, probationary PhD student at the Department of Chemical Engineering and Biotechnology. A 2019 Gates Cambridge Scholar, she has a passion for developing technologies that reduce the burden of infectious disease within global communities. Her previous research includes the development of a zebrafish model for epileptic encephalopathy, a genetic neurodevelopmental disorder characterized by intractable seizures, and the novel discovery of an anti-epileptic drug to treat the condition. Her future research at the University of Cambridge will involve the design of immunotherapies and diagnostics for Clostridioides difficile.
- 2015-2019 Arizona State University
- Biomedical Engineering, BSE
- Global Health, Minor
- 2019-2022 University of Cambridge
- Chemical Engineering, PhD
Publications
Piras, I., Mills, G., Llaci, L., Naymik, M., Ramsey, K., & Belnap, N. et al. (2017). Exploring genome-wide DNA methylation patterns in Aicardi syndrome. Epigenomics, 9(11), 1373-1386.